Negative regulation of osteoclast development

pathway activity — cross-omics
GO:2001205Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of osteoclast development pathway is significantly associated with the protein abundance of multiple proteins, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are IL16, SASH3, and SEPTIN1, each associated with the pathway in up to 10 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of osteoclast development activity versus IL16 in LSCC (Pearson r = 0.73).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCIL16 →+0.623+0.156<.001<.001310
OVSASH3 →+0.481+0.080.008<.00139
LSCCSEPTIN1 →+0.819+0.161<.001<.00139
GBMDOK2 →+0.637+0.077<.001<.00139
GBMHCLS1 →+0.675+0.084<.001<.00139
UCECLPXN →+0.522+0.092.003.00739
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:2001205 vs IL16 — LSCC

Per-sample scatter of Negative regulation of osteoclast development activity vs IL16 in LSCC.

Explore this scatter interactively →

Exploration